BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,047 filers reported holding BAXTER INTL INC in Q4 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,342,000 | 0.0% | 16,665 | 0.0% | 0.31% | +4.4% |
| Q2 2021 | $1,342,000 | -8.3% | 16,665 | -3.9% | 0.30% | -13.4% |
| Q1 2021 | $1,463,000 | +4.1% | 17,350 | -1.0% | 0.34% | -1.4% |
| Q4 2020 | $1,406,000 | +8.9% | 17,520 | +9.2% | 0.35% | -3.9% |
| Q3 2020 | $1,291,000 | -6.3% | 16,050 | +0.3% | 0.36% | -12.1% |
| Q2 2020 | $1,378,000 | +5.8% | 15,995 | -0.3% | 0.41% | -12.9% |
| Q1 2020 | $1,302,000 | -3.8% | 16,043 | -0.8% | 0.47% | +20.3% |
| Q4 2019 | $1,353,000 | -7.4% | 16,175 | -3.2% | 0.39% | -14.0% |
| Q3 2019 | $1,461,000 | +5.6% | 16,710 | -1.2% | 0.46% | +5.3% |
| Q2 2019 | $1,384,000 | +0.2% | 16,905 | -0.5% | 0.44% | -1.8% |
| Q1 2019 | $1,381,000 | +39.6% | 16,990 | +13.0% | 0.44% | +20.7% |
| Q4 2018 | $989,000 | -12.8% | 15,035 | +2.1% | 0.37% | +3.4% |
| Q3 2018 | $1,134,000 | -1.8% | 14,720 | -5.9% | 0.36% | -7.3% |
| Q2 2018 | $1,155,000 | +12.0% | 15,645 | -1.3% | 0.38% | +11.7% |
| Q1 2018 | $1,031,000 | -0.5% | 15,850 | -1.2% | 0.34% | +2.7% |
| Q4 2017 | $1,036,000 | -5.0% | 16,035 | -7.8% | 0.33% | -7.2% |
| Q3 2017 | $1,091,000 | +4.5% | 17,395 | +0.9% | 0.36% | +2.9% |
| Q2 2017 | $1,044,000 | +4.8% | 17,245 | -10.2% | 0.35% | +4.5% |
| Q1 2017 | $996,000 | +16.2% | 19,210 | -0.6% | 0.34% | +9.1% |
| Q4 2016 | $857,000 | -50.0% | 19,330 | -18.5% | 0.31% | -54.1% |
| Q2 2014 | $1,715,000 | +23.3% | 23,732 | +18.6% | 0.67% | +16.1% |
| Q4 2013 | $1,391,000 | – | 20,007 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tavio Capital LLC | 68,405 | $5,890,000 | 7.81% |
| Iron Triangle Partners LP | 330,000 | $28,413,000 | 7.16% |
| Veritas Asset Management LLP | 8,942,428 | $769,943,000 | 5.64% |
| TSFG, LLC | 93,405 | $8,042,000 | 5.31% |
| GENERATION INVESTMENT MANAGEMENT LLP | 10,606,094 | $913,185,000 | 5.27% |
| Third Point | 4,000,000 | $344,400,000 | 4.72% |
| Avidity Partners Management LP | 800,900 | $68,957,000 | 4.42% |
| Palmer Knight Co | 62,275 | $5,362,000 | 4.17% |
| Eos Focused Equity Management, L.P. | 36,786 | $3,167,000 | 3.70% |
| Dundas Partners LLP | 196,133 | $16,887,000 | 3.69% |